AVEN Antibody

ArtNr	CSB-PA335882-50ul
Hersteller	Cusabio
Menge	50 ul
Quantity options	100 ul 50 ul
Kategorie	Antibodies Immunohistochemistry Western Blot ELISA Cardiovascular Research Ischemia & Reperfusion Injury Primary Antibodies
Typ	Antibody Polyclonal
Format	Liquid
Applikationen	WB, IHC, ELISA
Specific against	Human (Homo sapiens), Mouse (Murine, Mus musculus)
Host	Rabbit
Isotype	IgG
Konjugat/Tag	Unconjugated
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Alias	1700013A01Rik antibody; 1700056A21Rik antibody; Apoptosis caspase activation inhibitor antibody; AVEN antibody; AVEN_HUMAN antibody; Cell death regulator Aven antibody; mAven L antibody; mAven S antibody; MGC124011 antibody; OTTMUSP00000016129 antibody; PDCD12 antibody; Programmed cell death 12 antibody; RP23-52C15.2 antibody
Similar products	apoptosis, caspase activation inhibitor
Lieferbar
Manufacturer - Type	Polyclonal Antibody
Manufacturer - Targets	AVEN
Storage Conditions	Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Manufacturer - Alias	1700013A01Rik antibody; 1700056A21Rik antibody; Apoptosis caspase activation inhibitor antibody; AVEN antibody; AVEN_HUMAN antibody; Cell death regulator Aven antibody; mAven L antibody; mAven S antibody; MGC124011 antibody; OTTMUSP00000016129 antibody; PDCD12 antibody; Programmed cell death 12 antibody; RP23-52C15.2 antibody
Immunogen Species	Human
Immunogen	Synthetic peptide of human AVEN
Dilution	ELISA:1:2000-1:5000 WB:1:500-1:2000 IHC:1:25-1:100
Background	AVEN, a cell death regulator, is an important signal inducer in acute leuke-mias. AVEN is a highly conserved peripheral membrane protein that protects the cell against the proteolytic activation of caspases as well as Apaf-1 mediated apoptosis by interfering with Apaf-1's ability to self-associate. Bcl-2 and Bad also interact with AVEN to prevent apoptosis. AVEN is highly expressed in ovary, heart, thymus, spleen, testis and colon, but can also be detected in other tissues. Erythropoietin and methylprednisolone may play important roles in the expression of AVEN in cardiac tissue, especially after a traumatic brain injury. In young patients suffering from acute lymphoblastic leukemia (ALL), AVEN expression may be a useful tool in prognosis prediction.
Buffer	-20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol
Purification Method	Antigen affinity purification
General Research Areas	Cell Biology
Initial Research Areas	Cell Biology
Antigen Species	Human
Antigen	Synthetic peptide of Human AVEN
Clonality	Polyclonal

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Arbeitsanleitung (Data Sheet) anfordern

CSB-PA335882-50ul-datasheet.pdf

Sicherheitsdatenblatt anfordern

Einfache Bestellung Periodische Bestellung

Menge: 50 ul

lieferbar

Lieferung vsl. bis 09.10.2025